BAMLET (NatImmune)

N/A

Report date: 2023/02/18 19:47:22

Base Information

Drug NameBAMLET (NatImmune)
Drug Alias NameBovine alpha-lactalbumin+Oleic acidBovine alpha-lactalbumin/Oleic acidbovine alpha-lactalbumin-lipid complex
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsUrinary Bladder Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNatimmune A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNatimmune A/S
Active IndicationsN/A
Inactive IndicationsUrinary Bladder Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A